Results 131 to 140 of about 1,690 (172)
Some of the next articles are maybe not open access.
Topical Sympatholytic Therapy for Pathologic Lid Retraction
Archives of Ophthalmology, 1967Patients with unilateral and bilateral lid retraction of diverse etiologies were treated with topical sympatholytic agents. The agents produced a partial Horner's syndrome, resulting in a decrease in lid retraction and symptoms of exposure. No systemic side effects occurred.
A J, Gay, M L, Salmon, M A, Wolkstein
openaire +2 more sources
Postoperative Pharmacokinetics and Sympatholytic Effects of Dexmedetomidine
Anesthesia & Analgesia, 1997Dexmedetomidine is a selective alpha2-adrenoceptor agonist with centrally mediated sympatholytic, sedative, and analgesic effects. This study evaluated: 1) pharmacokinetics of dexmedetomidine in plasma and cerebrospinal fluid (CSF) in surgical patients; 2) precision of a computer-controlled infusion protocol (CCIP) for dexmedetomidine during the ...
P, Talke +3 more
openaire +2 more sources
NEWER ADRENOLYTIC, SYMPATHOLYTIC, AND GANGLIONIC BLOCKING DRUGS
Journal of the American Medical Association, 1949Drugs capable of blocking vasoconstricting and blood pressure elevating effects of epinephrine have been known for many years. Early examples are ergotoxin, the Fourneau compound 933F and yohimbine. These drugs in higher dose range often depress sympathetic activity as judged by vasomotor reflexes.
K S, GRIMSON, J P, HENDRIX, M J, REARDON
openaire +2 more sources
Sympatholytic interventions and vascular remodelling.
Basic research in cardiology, 1991Most of the results on the effects of sympatholytic agents on vascular remodelling came from studies involving hypertensive animals. Therefore, it is often difficult to dissociate the antihypertensive property of the drugs from those caused by the direct action of the drugs on the structure of the blood vessels. However, some general conclusions can be
R M, Lee, D J, Gzik
openaire +1 more source